U.S patent court case scheduled for 14 September 2009>
U.S patent court case scheduled for 14 September 2009
(Thomson Reuters ONE) - Biotec Pharmacon has been informed by the U.S. District Court,District of Minnesota that the case regarding the remainingoutstanding patent issues with Biothera has been scheduled for 14September, 2009.Biothera had originally made claims under 14 U.S. patents, but allclaims under 12 of these patents were eliminated from furtherlitigation in a U.S. District Court Order in January 2009. The courtcase will thus only try Biothera's claims under two patents and twoclaims related to remarks attributed in the Norwegian press to formerexecutives of Biotec Pharmacon.Biotec Pharmacon welcomes the opportunity to present its evidence tothe U.S. District Court on these remaining issues.For further information, please contactLars Viksmoen, CEO Biotec Pharmacon, tel: +47 40620870CFO Jørn Lunde, CFO Biotec Pharmacon, tel: +47 90733486About Biotec:The biopharmaceutical company Biotec Pharmacon developspharmaceutical products for prevention and treatment of immunerelated diseases. The company has developed the bioactive substanceSBG (soluble beta glucan), which is in clinical phase III for twoindications; treatment of diabetic ulcers and prevention andtreatment of oral mucositis. The company's clinical developmentprogram also includes immune therapy of cancer, where combinationtreatments with SBG and monoclonal antibodies are being studied inclinical phase I/II. In addition, the company is involved in severalpreclinical studies with SBG. Biotec Pharmacon also produces andmarkets non-pharmaceutical health- and diagnostic products.This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.
" alt="Interim report January - June 2009 HL Display AB (publ)>">
" alt="ITCL - Extension of Charter>">
Datum: 16.07.2009 - 08:47 Uhr
Sprache: Deutsch
News-ID 3627
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 357 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"U.S patent court case scheduled for 14 September 2009>"
steht unter der journalistisch-redaktionellen Verantwortung von
Biotec Pharmacon ASA (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
